Luiz Flavio Andrade

Personal Details

First Name:	Luiz
Middle Name:	Flavio
Last Name:	Andrade
Suffix:
RePEc Short-ID:	pan370
	http://chaire-sante.essec.edu/home/equipe

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

1. Luiz Flavio Andrade, 2012. "Entry Time Effects and Follow-on Drugs Competition," Working Papers DT49, IRDES institut for research and information in health economics, revised Jun 2012.
   • Luiz Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
   • Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.
   • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.

   Cited by:

   1. Ana Beatriz D′Avó Luís & Mikyung Kelly Seo, 2021. "Has the development of cancer biomarkers to guide treatment improved health outcomes?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(5), pages 789-810, July.
   2. Mohamed Ali Ben Halima & Thierry Debrand & Camille Regaert, 2012. "Sick Leaves: Understanding Disparities Between French Departments," Working Papers DT50, IRDES institut for research and information in health economics, revised Oct 2012.
   3. Toon van der Gronde & Carin A Uyl-de Groot & Toine Pieters, 2017. "Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-34, August.

Articles

1. Luiz Flavio Andrade & Kristina Ludwig & Juan Manuel Ramos Goni & Mark Oppe & Gérard Pouvourville, 2020. "A French Value Set for the EQ-5D-5L," PharmacoEconomics, Springer, vol. 38(4), pages 413-425, April.

   Cited by:

   1. Chen-Wei Pan & Jun-Yi He & Yan-Bo Zhu & Chun-Hua Zhao & Nan Luo & Pei Wang, 2023. "Comparison of EQ-5D-5L and EORTC QLU-C10D utilities in gastric cancer patients," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(6), pages 885-893, August.
   2. Finch, Aureliano Paolo & Meregaglia, Michela & Ciani, Oriana & Roudijk, Bram & Jommi, Claudio, 2022. "An EQ-5D-5L value set for Italy using videoconferencing interviews and feasibility of a new mode of administration," Social Science & Medicine, Elsevier, vol. 292(C).
   3. Elena Olariu & Wael Mohammed & Yemi Oluboyede & Raluca Caplescu & Ileana Gabriela Niculescu-Aron & Marian Sorin Paveliu & Luke Vale, 2023. "EQ-5D-5L: a value set for Romania," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 399-412, April.
   4. Jungo, Katharina Tabea & Salari, Paola & Meier, Rahel & Bagattini, Michael & Spruit, Marco & Rodondi, Nicolas & Streit, Sven & Schwenkglenks, Matthias, 2024. "Cost-effectiveness of a medication review intervention for general practitioners and their multimorbid older patients with polypharmacy," Socio-Economic Planning Sciences, Elsevier, vol. 92(C).

2. L. F. Andrade & T. Rapp & C. Sevilla-Dedieu, 2018. "Quality of diabetes follow-up care and hospital admissions," International Journal of Health Economics and Management, Springer, vol. 18(2), pages 153-167, June.

   Cited by:

   1. C. Ugolini & M. Lippi Bruni & A. C. Leucci & G. Fiorentini & E. Berti & L. Nobilio & M. L. Moro, 2019. "Disease management in diabetes care: when involving GPs improves patient compliance and health outcomes," Working Papers wp1129, Dipartimento Scienze Economiche, Universita' di Bologna.
      • Ugolini, Cristina & Lippi Bruni, Matteo & Leucci, Anna Caterina & Fiorentini, Gianluca & Berti, Elena & Nobilio, Lucia & Moro, Maria Luisa, 2019. "Disease management in diabetes care: When involving GPs improves patient compliance and health outcomes," Health Policy, Elsevier, vol. 123(10), pages 955-962.
   2. Xin Wang & Kuimeng Song & Lijin Chen & Yixiang Huang & Stephen Birch, 2021. "Eliciting Preferences of Providers in Primary Care Settings for Post Hospital Discharge Patient Follow-Up," IJERPH, MDPI, vol. 18(16), pages 1-10, August.
   3. Laudicella, Mauro & Li Donni, Paolo & Prete, Vincenzo, 2024. "Healthcare utilisation by diabetic patients in Denmark: the role of primary care in reducing emergency visits," Health Policy, Elsevier, vol. 145(C).
   4. Iversen, Tor & Ching-to , Albert Ma, 2020. "Technology Adoption in Primary Health Care," HERO Online Working Paper Series 2020:4, University of Oslo, Health Economics Research Programme.
   5. Clémence Bussière & Nicolas Sirven & Thomas Rapp & Christine Sevilla‐dedieu, 2020. "Adherence to medical follow‐up recommendations reduces hospital admissions: Evidence from diabetic patients in France," Post-Print hal-03431397, HAL.
      • Clémence Bussière & Nicolas Sirven & Thomas Rapp & Christine Sevilla‐Dedieu, 2020. "Adherence to medical follow‐up recommendations reduces hospital admissions: Evidence from diabetic patients in France," Health Economics, John Wiley & Sons, Ltd., vol. 29(4), pages 508-522, April.
   6. Tor Iversen & Ching‐to Albert Ma, 2022. "Technology adoption by primary care physicians," Health Economics, John Wiley & Sons, Ltd., vol. 31(3), pages 443-465, March.

3. Luiz Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 45-60, January.
   • Luiz Flavio Andrade, 2011. "Entry time effects and follow on drug competition," Post-Print halshs-00658247, HAL.
   • Luiz Flavio Andrade, 2012. "Entry Time Effects and Follow-on Drugs Competition," Working Papers DT49, IRDES institut for research and information in health economics, revised Jun 2012.
   • Luiz Flavio Andrade & Catherine Sermet & Sylvain Pichetti, 2016. "Entry time effects and follow-on drug competition," Post-Print halshs-01156509, HAL.
   See citations under working paper version above.
4. Luiz Flavio Andrade & Thomas Rapp & Christine Sevilla-Dedieu, 2016. "Exploring the determinants of endocrinologist visits by patients with diabetes," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(9), pages 1173-1184, December.

   Cited by:

   1. Clémence Bussière & Nicolas Sirven & Thomas Rapp & Christine Sevilla‐dedieu, 2020. "Adherence to medical follow‐up recommendations reduces hospital admissions: Evidence from diabetic patients in France," Post-Print hal-03431397, HAL.
      • Clémence Bussière & Nicolas Sirven & Thomas Rapp & Christine Sevilla‐Dedieu, 2020. "Adherence to medical follow‐up recommendations reduces hospital admissions: Evidence from diabetic patients in France," Health Economics, John Wiley & Sons, Ltd., vol. 29(4), pages 508-522, April.

More information

Research fields, statistics, top rankings, if available.

Statistics

Access and download statistics for all items

Co-authorship network on CollEc

NEP Fields

NEP is an announcement service for new working papers, with a weekly report in each of many fields. This author has had 1 paper announced in NEP. These are the fields, ordered by number of announcements, along with their dates. If the author is listed in the directory of specialists for this field, a link is also provided.

1. NEP-COM: Industrial Competition (1) 2012-07-14
2. NEP-HME: Heterodox Microeconomics (1) 2012-07-14
3. NEP-IND: Industrial Organization (1) 2012-07-14
4. NEP-INO: Innovation (1) 2012-07-14
5. NEP-IPR: Intellectual Property Rights (1) 2012-07-14
6. NEP-TID: Technology and Industrial Dynamics (1) 2012-07-14

Corrections

All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Luiz Flavio Andrade should log into the RePEc Author Service.

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.